{"filing":{"accession_number":"0001193125-26-361705","cik":"0001831915","ticker":"CTKB","company_name":"Cytek Biosciences, Inc.","form":"8-K","filing_date":"2026-08-24","report_date":"2026-08-21","primary_document":"d137695d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1831915/000119312526361705/d137695d8k.htm"},"events":[{"id":29016,"run_id":26547,"accession_number":"0001193125-26-361705","anchor_item_number":"8.01","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"summary":"A jury found Cytek infringed one patent claim under the doctrine of equivalents in a patent infringement action brought by Beckman Coulter and awarded $56.11 million in damages ($20 million in lost profits and $36.11 million in royalties), although Cytek prevailed on three of four claims. The material damages award and ongoing litigation risk from post-trial motions and potential appeal materially affect the company's financial condition and legal exposure.","company_name":"Cytek Biosciences, Inc.","ticker":"CTKB","filing_date":"2026-08-24","form":"8-K","submitted_at":null,"items":[{"id":31140,"accession_number":"0001193125-26-361705","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"The disclosure announces a jury verdict in a patent infringement action brought by Beckman Coulter against Cytek. The jury found infringement under the doctrine of equivalents on one claim and awarded $56 million in damages ($20 million in lost profits and $36 million in royalties). Although Cytek prevailed on three of four claims, the remaining finding and substantial damages award materially affect the company's financial condition and legal exposure, making this a material litigation event requiring disclosure under Item 8.01 (disclosed here as Item 7.01 Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-24T10:03:48.530305+00:00","company_name":"","ticker":null,"filing_date":""},{"id":31141,"accession_number":"0001193125-26-361705","item_number":"8.01","item_title":"Other Events.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"The disclosure reports a jury verdict in a patent infringement action brought by Beckman Coulter against Cytek. The jury found infringement under the doctrine of equivalents on one claim and awarded $56.11 million in damages ($20 million in lost profits and $36.11 million in royalties). Although Cytek prevailed on three of four claims, the material damages award and ongoing litigation risk (post-trial motions and potential appeal) constitute a material litigation event that would affect a reasonable investor's assessment of the company's financial condition and legal exposure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-24T10:03:48.530305+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":31140,"accession_number":"0001193125-26-361705","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"The disclosure announces a jury verdict in a patent infringement action brought by Beckman Coulter against Cytek. The jury found infringement under the doctrine of equivalents on one claim and awarded $56 million in damages ($20 million in lost profits and $36 million in royalties). Although Cytek prevailed on three of four claims, the remaining finding and substantial damages award materially affect the company's financial condition and legal exposure, making this a material litigation event requiring disclosure under Item 8.01 (disclosed here as Item 7.01 Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-24T10:03:48.530305+00:00","company_name":"Cytek Biosciences, Inc.","ticker":"CTKB","filing_date":"2026-08-24"},{"id":31141,"accession_number":"0001193125-26-361705","item_number":"8.01","item_title":"Other Events.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"The disclosure reports a jury verdict in a patent infringement action brought by Beckman Coulter against Cytek. The jury found infringement under the doctrine of equivalents on one claim and awarded $56.11 million in damages ($20 million in lost profits and $36.11 million in royalties). Although Cytek prevailed on three of four claims, the material damages award and ongoing litigation risk (post-trial motions and potential appeal) constitute a material litigation event that would affect a reasonable investor's assessment of the company's financial condition and legal exposure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-24T10:03:48.530305+00:00","company_name":"Cytek Biosciences, Inc.","ticker":"CTKB","filing_date":"2026-08-24"}]}